Department of Cardiology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.
Clinic of Cardiology, Kayseri City Hospital, Kayseri, Turkey.
Balkan Med J. 2021 May;38(3):183-189. doi: 10.5152/balkanmedj.2021.21143.
Indications and appropriateness of aspirin use have not been well investigated in Turkey.
To investigate the prescription patterns and appropriateness of aspirin in a real-world clinical setting.
Cross-sectional study.
The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) is a cross-sectional and multicenter study that included 5007 consecutive patients aged 18 or over who presented to 30 different cardiology outpatient clinics from 14 cities throughout Turkey. Only patients using aspirin (80-325 mg) were included. The study population was divided into 2 groups regarding the use of aspirin: primary prevention (PP) group and secondary prevention (SP) group. The indication of aspirin use was evaluated following the 2016 European Society of Cardiology (ESC) and the 2016 United States Preventative Services Task Force (USPTF) guidelines in the PP group.
A total of 5007 patients (mean age 62.15 ± 11.05, 39% female) were enrolled. The PP group included 1132 (22.6%) patients, and the SP group included 3875 (77.4%) patients. Of the 1132 patients, inappropriate use of aspirin was determined in 100% of the patients according to the ESC guidelines, and 71% of the patients according to the USPTF guidelines. Multivariate logistic regression analysis showed age OR: 0.98 CI (0.97-0.99) P = .037, smoking OR: 0.60 CI (0.44-0.82) P = .001, heart failure OR: 2.11 CI (1.14-3.92) P = .017, hypertension OR: 0.51 CI (0.36-0.74) P < .001, diabetes mellitus OR: 0.34 CI (0.25-0.47) P < .001, oral anticoagulant use OR: 3.01 CI (1.10-8.25) P = .032, and female sex OR: 2.73 CI (1.96-3.80) P < .001 were independent predictors of inappropriate aspirin use in PP patients.
Although there are considerable differences between the USPTF and the ESC guidelines with respect to recommendations for aspirin use in PP, inappropriate use of aspirin in Turkey is frequent in real-world practice for both guidelines. Besides, heart failure, oral anticoagulant use, and the female sex of the patients were independent predictors of inappropriate use of aspirin.
在土耳其,阿司匹林的使用指征和适宜性尚未得到充分研究。
在真实临床环境中调查阿司匹林的处方模式和适宜性。
横断面研究。
《门诊患者中阿司匹林使用适宜性评估:多中心、观察性研究》(ASSOS)是一项横断面和多中心研究,纳入了来自土耳其 14 个城市 30 个不同心内科门诊的 5007 例年龄在 18 岁及以上的连续患者。仅纳入使用阿司匹林(80-325mg)的患者。根据欧洲心脏病学会(ESC)2016 年和美国预防服务工作组(USPTF)2016 年的指南,将研究人群分为 2 组:阿司匹林一级预防(PP)组和二级预防(SP)组。根据 2016 年 ESC 和 2016 年 USPTF 指南,评估阿司匹林使用的指征。
共纳入 5007 例患者(平均年龄 62.15±11.05 岁,39%为女性)。PP 组 1132 例(22.6%),SP 组 3875 例(77.4%)。根据 ESC 指南,1132 例患者中阿司匹林的使用均不适宜,根据 USPTF 指南,有 71%的患者阿司匹林使用不适宜。多因素 logistic 回归分析显示,年龄 OR:0.98(0.97-0.99)P =.037,吸烟 OR:0.60(0.44-0.82)P =.001,心力衰竭 OR:2.11(1.14-3.92)P =.017,高血压 OR:0.51(0.36-0.74)P <.001,糖尿病 OR:0.34(0.25-0.47)P <.001,口服抗凝剂使用 OR:3.01(1.10-8.25)P =.032,女性 OR:2.73(1.96-3.80)P <.001 是 PP 患者阿司匹林使用不适宜的独立预测因素。
尽管 USPTF 和 ESC 指南在阿司匹林用于 PP 患者的推荐方面存在较大差异,但在土耳其的实际实践中,两种指南下阿司匹林的不适当使用都很常见。此外,心力衰竭、口服抗凝剂的使用和患者的女性性别是阿司匹林使用不当的独立预测因素。